Review




Structured Review

Autodesk Inc microfluidic chip virtual model
The schematic diagram of the drug screening biomimetic <t>microfluidic</t> chip. bFGF: Basic fibroblast growth factor; CCU: cell culture unit; CGG: concentration gradient generator; NGF: nerve growth factor.
Microfluidic Chip Virtual Model, supplied by Autodesk Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microfluidic chip virtual model/product/Autodesk Inc
Average 90 stars, based on 1 article reviews
microfluidic chip virtual model - by Bioz Stars, 2026-05
90/100 stars

Images

1) Product Images from "Nerve growth factor-basic fibroblast growth factor poly-lactide co-glycolid sustained-release microspheres and the small gap sleeve bridging technique to repair peripheral nerve injury"

Article Title: Nerve growth factor-basic fibroblast growth factor poly-lactide co-glycolid sustained-release microspheres and the small gap sleeve bridging technique to repair peripheral nerve injury

Journal: Neural Regeneration Research

doi: 10.4103/1673-5374.344842

The schematic diagram of the drug screening biomimetic microfluidic chip. bFGF: Basic fibroblast growth factor; CCU: cell culture unit; CGG: concentration gradient generator; NGF: nerve growth factor.
Figure Legend Snippet: The schematic diagram of the drug screening biomimetic microfluidic chip. bFGF: Basic fibroblast growth factor; CCU: cell culture unit; CGG: concentration gradient generator; NGF: nerve growth factor.

Techniques Used: Drug discovery, Cell Culture, Concentration Assay

Virtual model and schematic of a drug screening biomimetic microfluidic chip. The chip comprises an upstream CGG and downstream parallel CCU, and includes two inlet ports, one liquid outlet, one drug CGG and eight cell culture chambers. CCU: Cell culture unit; CGG: concentration gradient generator.
Figure Legend Snippet: Virtual model and schematic of a drug screening biomimetic microfluidic chip. The chip comprises an upstream CGG and downstream parallel CCU, and includes two inlet ports, one liquid outlet, one drug CGG and eight cell culture chambers. CCU: Cell culture unit; CGG: concentration gradient generator.

Techniques Used: Drug discovery, Cell Culture, Concentration Assay

Identification of drug concentration gradients of the biomimetic microfluidic chips. (A) Images 1–8 represent eight concentration gradients (more details of concentrations are shown in ). (B) The difference between the theoretical and experimental data of a concentration gradient generator. Data are expressed as mean ± SD. The study was repeated three times.
Figure Legend Snippet: Identification of drug concentration gradients of the biomimetic microfluidic chips. (A) Images 1–8 represent eight concentration gradients (more details of concentrations are shown in ). (B) The difference between the theoretical and experimental data of a concentration gradient generator. Data are expressed as mean ± SD. The study was repeated three times.

Techniques Used: Concentration Assay

Screening of the drug concentration in primary Schwann cells. (A) Live and dead cell staining of rat Schwann cells under eight different NGF/bFGF drug concentrations on the microfluidic chip. Green is AO stained cells (live), red is PI stained cells (dead). The cell number and proliferation rate of Schwann cells gradually increased from the 1 st chamber to the 4 th chamber, and gradually decreased from the 4 th chamber to the 8 th chamber, reaching a peak in the 4 th chamber (22.86 ng/mL NGF combined with 4.29 ng/mL bFGF). Scale bars: 25 μm. (B) Cell proliferation rate (cell number after culture with NGF/bFGF/initially implanted cell number × 100) under eight different concentrations. (C) Cell number after culture with NGF/bFGF under eight different drug concentrations. Data are expressed as mean ± SD. The above experiments were independently repeated three times. * P < 0.05, vs . other groups (one-way analysis of variance followed by Bonferroni post hoc test). 1–8: Cell culture chambers. AO: Acridine orange solution; bFGF: basic fibroblast growth factor; NGF: nerve growth factor; PI: propidium iodide.
Figure Legend Snippet: Screening of the drug concentration in primary Schwann cells. (A) Live and dead cell staining of rat Schwann cells under eight different NGF/bFGF drug concentrations on the microfluidic chip. Green is AO stained cells (live), red is PI stained cells (dead). The cell number and proliferation rate of Schwann cells gradually increased from the 1 st chamber to the 4 th chamber, and gradually decreased from the 4 th chamber to the 8 th chamber, reaching a peak in the 4 th chamber (22.86 ng/mL NGF combined with 4.29 ng/mL bFGF). Scale bars: 25 μm. (B) Cell proliferation rate (cell number after culture with NGF/bFGF/initially implanted cell number × 100) under eight different concentrations. (C) Cell number after culture with NGF/bFGF under eight different drug concentrations. Data are expressed as mean ± SD. The above experiments were independently repeated three times. * P < 0.05, vs . other groups (one-way analysis of variance followed by Bonferroni post hoc test). 1–8: Cell culture chambers. AO: Acridine orange solution; bFGF: basic fibroblast growth factor; NGF: nerve growth factor; PI: propidium iodide.

Techniques Used: Concentration Assay, Staining, Cell Culture



Similar Products

90
Autodesk Inc microfluidic chip virtual model
The schematic diagram of the drug screening biomimetic <t>microfluidic</t> chip. bFGF: Basic fibroblast growth factor; CCU: cell culture unit; CGG: concentration gradient generator; NGF: nerve growth factor.
Microfluidic Chip Virtual Model, supplied by Autodesk Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microfluidic chip virtual model/product/Autodesk Inc
Average 90 stars, based on 1 article reviews
microfluidic chip virtual model - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


The schematic diagram of the drug screening biomimetic microfluidic chip. bFGF: Basic fibroblast growth factor; CCU: cell culture unit; CGG: concentration gradient generator; NGF: nerve growth factor.

Journal: Neural Regeneration Research

Article Title: Nerve growth factor-basic fibroblast growth factor poly-lactide co-glycolid sustained-release microspheres and the small gap sleeve bridging technique to repair peripheral nerve injury

doi: 10.4103/1673-5374.344842

Figure Lengend Snippet: The schematic diagram of the drug screening biomimetic microfluidic chip. bFGF: Basic fibroblast growth factor; CCU: cell culture unit; CGG: concentration gradient generator; NGF: nerve growth factor.

Article Snippet: The microfluidic chip virtual model was designed using Autodesk AutoCAD software.

Techniques: Drug discovery, Cell Culture, Concentration Assay

Virtual model and schematic of a drug screening biomimetic microfluidic chip. The chip comprises an upstream CGG and downstream parallel CCU, and includes two inlet ports, one liquid outlet, one drug CGG and eight cell culture chambers. CCU: Cell culture unit; CGG: concentration gradient generator.

Journal: Neural Regeneration Research

Article Title: Nerve growth factor-basic fibroblast growth factor poly-lactide co-glycolid sustained-release microspheres and the small gap sleeve bridging technique to repair peripheral nerve injury

doi: 10.4103/1673-5374.344842

Figure Lengend Snippet: Virtual model and schematic of a drug screening biomimetic microfluidic chip. The chip comprises an upstream CGG and downstream parallel CCU, and includes two inlet ports, one liquid outlet, one drug CGG and eight cell culture chambers. CCU: Cell culture unit; CGG: concentration gradient generator.

Article Snippet: The microfluidic chip virtual model was designed using Autodesk AutoCAD software.

Techniques: Drug discovery, Cell Culture, Concentration Assay

Identification of drug concentration gradients of the biomimetic microfluidic chips. (A) Images 1–8 represent eight concentration gradients (more details of concentrations are shown in ). (B) The difference between the theoretical and experimental data of a concentration gradient generator. Data are expressed as mean ± SD. The study was repeated three times.

Journal: Neural Regeneration Research

Article Title: Nerve growth factor-basic fibroblast growth factor poly-lactide co-glycolid sustained-release microspheres and the small gap sleeve bridging technique to repair peripheral nerve injury

doi: 10.4103/1673-5374.344842

Figure Lengend Snippet: Identification of drug concentration gradients of the biomimetic microfluidic chips. (A) Images 1–8 represent eight concentration gradients (more details of concentrations are shown in ). (B) The difference between the theoretical and experimental data of a concentration gradient generator. Data are expressed as mean ± SD. The study was repeated three times.

Article Snippet: The microfluidic chip virtual model was designed using Autodesk AutoCAD software.

Techniques: Concentration Assay

Screening of the drug concentration in primary Schwann cells. (A) Live and dead cell staining of rat Schwann cells under eight different NGF/bFGF drug concentrations on the microfluidic chip. Green is AO stained cells (live), red is PI stained cells (dead). The cell number and proliferation rate of Schwann cells gradually increased from the 1 st chamber to the 4 th chamber, and gradually decreased from the 4 th chamber to the 8 th chamber, reaching a peak in the 4 th chamber (22.86 ng/mL NGF combined with 4.29 ng/mL bFGF). Scale bars: 25 μm. (B) Cell proliferation rate (cell number after culture with NGF/bFGF/initially implanted cell number × 100) under eight different concentrations. (C) Cell number after culture with NGF/bFGF under eight different drug concentrations. Data are expressed as mean ± SD. The above experiments were independently repeated three times. * P < 0.05, vs . other groups (one-way analysis of variance followed by Bonferroni post hoc test). 1–8: Cell culture chambers. AO: Acridine orange solution; bFGF: basic fibroblast growth factor; NGF: nerve growth factor; PI: propidium iodide.

Journal: Neural Regeneration Research

Article Title: Nerve growth factor-basic fibroblast growth factor poly-lactide co-glycolid sustained-release microspheres and the small gap sleeve bridging technique to repair peripheral nerve injury

doi: 10.4103/1673-5374.344842

Figure Lengend Snippet: Screening of the drug concentration in primary Schwann cells. (A) Live and dead cell staining of rat Schwann cells under eight different NGF/bFGF drug concentrations on the microfluidic chip. Green is AO stained cells (live), red is PI stained cells (dead). The cell number and proliferation rate of Schwann cells gradually increased from the 1 st chamber to the 4 th chamber, and gradually decreased from the 4 th chamber to the 8 th chamber, reaching a peak in the 4 th chamber (22.86 ng/mL NGF combined with 4.29 ng/mL bFGF). Scale bars: 25 μm. (B) Cell proliferation rate (cell number after culture with NGF/bFGF/initially implanted cell number × 100) under eight different concentrations. (C) Cell number after culture with NGF/bFGF under eight different drug concentrations. Data are expressed as mean ± SD. The above experiments were independently repeated three times. * P < 0.05, vs . other groups (one-way analysis of variance followed by Bonferroni post hoc test). 1–8: Cell culture chambers. AO: Acridine orange solution; bFGF: basic fibroblast growth factor; NGF: nerve growth factor; PI: propidium iodide.

Article Snippet: The microfluidic chip virtual model was designed using Autodesk AutoCAD software.

Techniques: Concentration Assay, Staining, Cell Culture